• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂蛋白(a)与肺栓塞严重程度——一项回顾性数据分析

Lipoprotein(a) and Pulmonary Embolism Severity-A Retrospective Data Analysis.

作者信息

Gressenberger Paul, Posch Florian, Pechtold Moritz, Gütl Katharina, Muster Viktoria, Jud Philipp, Riedl Jakob, Silbernagel Günther, Kolesnik Ewald, Schmid Johannes, Raggam Reinhard B, Brodmann Marianne, Gary Thomas

机构信息

Division of Angiology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

出版信息

Front Cardiovasc Med. 2022 Feb 7;9:808605. doi: 10.3389/fcvm.2022.808605. eCollection 2022.

DOI:10.3389/fcvm.2022.808605
PMID:35198612
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8858967/
Abstract

AIM

We aimed to investigate a correlation between PE severity and Lp(a) levels.

METHODS

We performed a retrospective data analysis from our medical records of PE patients admitted to the University Hospital Graz, Austria. Patients with an Lp(a) reading within a 1-year interval before and after PE diagnosis were included. In accordance with the 2019 ESC guidelines for the diagnosis and management of acute PE, severity assessment was carried out classifying patients into four groups: low risk (LR), intermediate low risk (IML), intermediate high risk (IMH) and high risk (HR). The study period of interest was between January 1, 2002 and August 1, 2020.

RESULTS

We analyzed 811 patients with PE, of whom 323 (40%) had low-risk PE, 343 (42%) had intermediate-low-risk PE, 64 (8%) had intermediate-high-risk PE, and 81 (10%) had high-risk PE, respectively. We did not observe an association between PE severity and Lp(a) concentrations. In detail, median Lp(a) concentrations were 17 mg/dL [25-75th percentile: 10-37] in low-risk PE patients, 16 mg/dL [10-37] in intermediate-low-risk PE patients, 15mg/dL [10-48] in intermediate-high-risk PE patients, and 13mg/dL [10-27] in high-risk PE patients, respectively (Kruskal-Wallis = 0.658, p for linear trend = 0.358).

CONCLUSION

The current findings suggest no correlation between PE severity and Lp(a) levels.

摘要

目的

我们旨在研究肺栓塞(PE)严重程度与脂蛋白(a)[Lp(a)]水平之间的相关性。

方法

我们对奥地利格拉茨大学医院收治的PE患者的病历进行了回顾性数据分析。纳入在PE诊断前后1年内有Lp(a)读数的患者。根据2019年欧洲心脏病学会(ESC)急性PE诊断和管理指南,对患者进行严重程度评估并分为四组:低风险(LR)、中低风险(IML)、中高风险(IMH)和高风险(HR)。研究时间段为2002年1月1日至2020年8月1日。

结果

我们分析了811例PE患者,其中分别有323例(40%)为低风险PE、343例(42%)为中低风险PE、64例(8%)为中高风险PE和81例(10%)为高风险PE。我们未观察到PE严重程度与Lp(a)浓度之间存在关联。具体而言,低风险PE患者的Lp(a)浓度中位数为17mg/dL[第25 - 75百分位数:10 - 37],中低风险PE患者为16mg/dL[10 - 37],中高风险PE患者为15mg/dL[10 - 48],高风险PE患者为13mg/dL[10 - 27](Kruskal - Wallis检验=0.658,线性趋势p值=0.358)。

结论

目前的研究结果表明PE严重程度与Lp(a)水平之间无相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fa5/8858967/4d3daa42edf5/fcvm-09-808605-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fa5/8858967/4d3daa42edf5/fcvm-09-808605-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fa5/8858967/4d3daa42edf5/fcvm-09-808605-g0001.jpg

相似文献

1
Lipoprotein(a) and Pulmonary Embolism Severity-A Retrospective Data Analysis.脂蛋白(a)与肺栓塞严重程度——一项回顾性数据分析
Front Cardiovasc Med. 2022 Feb 7;9:808605. doi: 10.3389/fcvm.2022.808605. eCollection 2022.
2
Pulmonary embolism risk stratification by European Society of Cardiology is associated with recurrent venous thromboembolism: Findings from a long-term follow-up study.欧洲心脏病学会的肺栓塞风险分层与复发性静脉血栓栓塞相关:一项长期随访研究的结果
Int J Cardiol. 2016 Jan 1;202:275-81. doi: 10.1016/j.ijcard.2014.09.142. Epub 2014 Oct 5.
3
The timing of death in acute pulmonary embolism patients regarding the mortality risk stratification at admission to the hospital.急性肺栓塞患者死亡时间与入院时死亡风险分层的关系。
Heliyon. 2023 Dec 12;10(1):e23536. doi: 10.1016/j.heliyon.2023.e23536. eCollection 2024 Jan 15.
4
Lipoprotein (a) in patients with spontaneous venous thromboembolism.自发性静脉血栓栓塞患者的脂蛋白(a)
Thromb Res. 2007;120(1):15-20. doi: 10.1016/j.thromres.2006.03.002. Epub 2006 Apr 27.
5
Physician failure to stratify patients hospitalized with acute pulmonary embolism.医生未对急性肺栓塞住院患者进行分层。
Hosp Pract (1995). 2017 Dec;45(5):181-186. doi: 10.1080/21548331.2017.1372033. Epub 2017 Aug 30.
6
Risk stratification of patients with acute symptomatic pulmonary embolism.急性有症状肺栓塞患者的风险分层。
Intern Emerg Med. 2016 Feb;11(1):11-8. doi: 10.1007/s11739-015-1388-0. Epub 2016 Jan 14.
7
Renal dysfunction improves risk stratification and may call for a change in the management of intermediate- and high-risk acute pulmonary embolism: results from a multicenter cohort study with external validation.肾功能障碍可改善风险分层,可能需要改变中高危急性肺栓塞的治疗方法:多中心队列研究的结果及外部验证。
Crit Care. 2021 Feb 9;25(1):57. doi: 10.1186/s13054-021-03458-z.
8
Low-density lipoprotein apheresis: an evidence-based analysis.低密度脂蛋白单采术:一项基于证据的分析。
Ont Health Technol Assess Ser. 2007;7(5):1-101. Epub 2006 Nov 1.
9
Assessment of coexisting deep vein thrombosis for risk stratification of acute pulmonary embolism.评估合并深静脉血栓形成对急性肺栓塞危险分层的价值。
Thromb Res. 2018 Apr;164:40-44. doi: 10.1016/j.thromres.2018.02.140. Epub 2018 Feb 17.
10
Association between risk stratification for pulmonary embolism and deep vein thrombosis of lower extremities.下肢深静脉血栓形成与肺栓塞风险分层的关系。
Clin Respir J. 2020 Jul;14(7):631-637. doi: 10.1111/crj.13177. Epub 2020 Mar 11.

引用本文的文献

1
Association of Lipoprotein(a) With Cardiovascular and Cerebrovascular Disease in a Nationally Representative Cohort of Germany.德国全国代表性队列中脂蛋白(a)与心血管和脑血管疾病的关联
JACC Adv. 2025 Jul 23;4(8):102015. doi: 10.1016/j.jacadv.2025.102015.
2
Lipoprotein (a) is not associated with thrombus burden derived from CT pulmonary angiography in patients with acute pulmonary embolism.脂蛋白(a)与急性肺栓塞患者 CT 肺动脉造影显示的血栓负荷无关。
Sci Rep. 2024 Oct 29;14(1):25962. doi: 10.1038/s41598-024-77669-z.
3
The relationship between lipoprotein(a) and risk of cardiovascular disease: a Mendelian randomization analysis.

本文引用的文献

1
How significant is the antifibrinolytic effect of lipoprotein(a) for blood clot lysis?脂蛋白(a)的抗纤维蛋白溶解作用对血凝块溶解的影响有多大?
Thromb Res. 2021 Feb;198:210-212. doi: 10.1016/j.thromres.2020.12.014. Epub 2020 Dec 26.
2
The 2019 ESC Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism.2019年欧洲心脏病学会急性肺栓塞诊断和管理指南。
Eur Heart J. 2019 Nov 1;40(42):3453-3455. doi: 10.1093/eurheartj/ehz726.
3
Potent reduction of plasma lipoprotein (a) with an antisense oligonucleotide in human subjects does not affect ex vivo fibrinolysis.
载脂蛋白(a)与心血管疾病风险的关系:一项孟德尔随机化分析。
Eur J Med Res. 2022 Oct 27;27(1):211. doi: 10.1186/s40001-022-00825-6.
在人体中,用反义寡核苷酸强力降低血浆脂蛋白(a)不会影响体外纤溶。
J Lipid Res. 2019 Dec;60(12):2082-2089. doi: 10.1194/jlr.P094763. Epub 2019 Sep 24.
4
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.2019年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南:通过血脂修饰降低心血管风险
Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455.
5
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association.脂蛋白(a)在临床实践中的应用:是时候使用这个标志物了。美国国家脂质协会的科学声明。
J Clin Lipidol. 2019 May-Jun;13(3):374-392. doi: 10.1016/j.jacl.2019.04.010. Epub 2019 May 17.
6
Statin therapy increases lipoprotein(a) levels.他汀类药物治疗会升高脂蛋白(a)水平。
Eur Heart J. 2020 Jun 21;41(24):2275-2284. doi: 10.1093/eurheartj/ehz310.
7
Validation of simplified PESI score for identification of low-risk patients with pulmonary embolism: From the COMMAND VTE Registry.简化的 PESI 评分对肺栓塞低危患者的评估:来自 COMMAND VTE 注册研究。
Eur Heart J Acute Cardiovasc Care. 2020 Jun;9(4):262-270. doi: 10.1177/2048872618799993. Epub 2018 Sep 11.
8
Lipoprotein(a).脂蛋白(a)
Eur Heart J. 2017 May 21;38(20):1530-1532. doi: 10.1093/eurheartj/ehx233.
9
Statins as a preventative therapy for venous thromboembolism.他汀类药物作为静脉血栓栓塞的预防性治疗方法。
Cardiovasc Diagn Ther. 2017 Dec;7(Suppl 3):S207-S218. doi: 10.21037/cdt.2017.09.12.
10
Lipoprotein(a) as a Risk Factor for Venous Thromboembolism: A Systematic Review and Meta-analysis of the Literature.脂蛋白(a)作为静脉血栓栓塞的风险因素:文献的系统评价和荟萃分析。
Semin Thromb Hemost. 2017 Sep;43(6):614-620. doi: 10.1055/s-0036-1598002. Epub 2017 Mar 27.